Simulations Plus Inc
SLP15.860USD
+0.430+2.79%
Fechamento 09/18, 16:00（ET）Cotações atrasadas em 15 min
319.04MValor de mercado
PerdaP/L TTM
Mais detalhes de Simulations Plus Inc Empresa
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Informações da empresa
Código da empresaSLP
Nome da EmpresaSimulations Plus Inc
Data de listagemJun 18, 1997
CEOMr. Shawn M. O'Connor
Número de funcionários243
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 18
Endereço800 Park Offices Drive, Suite 401
CidadeRESEARCH TRIANGLE PARK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27709
Telefone16617237723
Sitehttps://www.simulations-plus.com/
Código da empresaSLP
Data de listagemJun 18, 1997
CEOMr. Shawn M. O'Connor
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.31M
+0.06%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
11.51K
+21.98%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
8.93K
+30.27%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven Chang
Mr. Steven Chang
Global Head - Strategic Alliances
Global Head - Strategic Alliances
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.31M
+0.06%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
11.51K
+21.98%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
8.93K
+30.27%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Software licenses
13.48M
60.11%
Consulting services
8.95M
39.89%
Por RegiãoUSD
Nome
Receita
Proporção
Americas
16.11M
71.83%
Europe
4.81M
21.42%
Asia
1.51M
6.75%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Software licenses
13.48M
60.11%
Consulting services
8.95M
39.89%
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Woltosz (Walter S)
16.43%
BlackRock Institutional Trust Company, N.A.
11.18%
Conestoga Capital Advisors, LLC
6.37%
The Vanguard Group, Inc.
5.82%
Janus Henderson Investors
4.04%
Outro
56.17%
Investidores
Investidores
Proporção
Woltosz (Walter S)
16.43%
BlackRock Institutional Trust Company, N.A.
11.18%
Conestoga Capital Advisors, LLC
6.37%
The Vanguard Group, Inc.
5.82%
Janus Henderson Investors
4.04%
Outro
56.17%
Tipos de investidores
Investidores
Proporção
Investment Advisor
40.48%
Investment Advisor/Hedge Fund
32.33%
Individual Investor
17.38%
Hedge Fund
6.28%
Research Firm
3.95%
Pension Fund
1.75%
Bank and Trust
1.12%
Venture Capital
0.10%
Sovereign Wealth Fund
0.04%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
397
20.10M
99.87%
-2.39M
2025Q1
405
20.80M
103.44%
-1.07M
2024Q4
395
19.75M
98.32%
-353.54K
2024Q3
400
19.32M
96.55%
-155.06K
2024Q2
401
20.11M
100.50%
-787.76K
2024Q1
398
20.05M
100.34%
-310.16K
2023Q4
390
19.56M
97.97%
-570.84K
2023Q3
390
19.23M
96.46%
-1.16M
2023Q2
406
19.53M
98.02%
-1.10M
2023Q1
421
19.42M
97.11%
-1.40M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Woltosz (Walter S)
3.32M
16.53%
-20.00K
-0.60%
Jun 02, 2025
BlackRock Institutional Trust Company, N.A.
2.29M
11.38%
-24.85K
-1.07%
Mar 31, 2025
Conestoga Capital Advisors, LLC
2.61M
12.97%
+383.13K
+17.21%
Mar 31, 2025
The Vanguard Group, Inc.
1.10M
5.45%
-47.76K
-4.18%
Mar 31, 2025
Janus Henderson Investors
896.34K
4.46%
+353.44K
+65.10%
Mar 31, 2025
State Street Global Advisors (US)
706.51K
3.51%
-14.51K
-2.01%
Mar 31, 2025
Columbia Threadneedle Investments (UK)
422.80K
2.1%
+28.38K
+7.20%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
475.53K
2.36%
+56.29K
+13.43%
Mar 31, 2025
Geode Capital Management, L.L.C.
385.85K
1.92%
-14.76K
-3.69%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
First Trust Active Factor Small Cap ETF
0%
iShares ESG Select Screened S&P Small-Cap ETF
0%
Global X Russell 2000 ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
Invesco S&P SmallCap 600 Revenue ETF
0%
Global X HealthTech ETF
0%
Ver Mais
Proshares Ultra Russell 2000
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
Proporção0%
DFA Dimensional US Core Equity Market ETF
Proporção0%
First Trust Active Factor Small Cap ETF
Proporção0%
iShares ESG Select Screened S&P Small-Cap ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
SPDR Portfolio MSCI Global Stock Market ETF
Proporção0%
Invesco S&P SmallCap 600 Revenue ETF
Proporção0%
Global X HealthTech ETF
Proporção0%
Dividendo
Um total de
23.51M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jul 02, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024
Jul 29, 2024
Aug 05, 2024
Jul 29, 2024
Apr 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024
Apr 29, 2024
May 06, 2024
Apr 26, 2024
Jan 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024
Jan 29, 2024
Feb 05, 2024
Jan 26, 2024
Oct 25, 2023
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023
Oct 30, 2023
Nov 06, 2023
Oct 27, 2023
Jul 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023
Jul 31, 2023
Aug 07, 2023
Jul 28, 2023
Apr 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023
Apr 24, 2023
May 01, 2023
Apr 21, 2023
Jan 05, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023
Jan 30, 2023
Feb 06, 2023
Jan 27, 2023
Oct 20, 2022
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022
Oct 31, 2022
Nov 07, 2022
Oct 28, 2022
Jul 07, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022
Jul 25, 2022
Aug 01, 2022
Jul 22, 2022
Apr 06, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022
Apr 25, 2022
May 02, 2022
Apr 22, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
